5439042026-01-012026-03-315439042026-03-315439042025-03-315439042025-04-012026-03-315439042026-01-012026-03-31in-capmkt:OtherExpenses1Member5439042025-04-012026-03-31in-capmkt:OtherExpenses1Member5439042026-03-31OtherNoncurrentFinancialAssetsDomain15439042026-03-31OtherNoncurrentAssetsDomain15439042026-03-31OtherCurrentFinancialAssetsDomain15439042026-03-31OtherCurrentAssetsDomain15439042026-03-31OtherNoncurrentLiabilitiesDomain15439042026-03-31OtherCurrentFinancialLiabilitiesDomain15439042026-03-31OtherCurrentLiabilitiesDomain15439042026-01-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15439042026-01-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss25439042026-01-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss35439042026-01-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss45439042025-04-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15439042025-04-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss25439042025-04-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss35439042025-04-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss45439042026-01-012026-03-31ItemsThatWillBeReclassifiedToProfitAndLoss15439042025-04-012026-03-31ItemsThatWillBeReclassifiedToProfitAndLoss15439042026-01-012026-03-31AuditorDomain15439042026-01-012026-03-31AuditorDomain2iso4217:INRxbrli:pureiso4217:INRxbrli:shares543904MANKINDNOTLISTEDINE634S01028MANKIND PHARMA LIMITEDMain BoardEquity2025-04-012026-03-312026-05-192026-05-07INRCroresQuarterlyFourth quarterSingle segmentPharmaceuticals2026-05-1915:10:002026-05-1916:30:00trueCash Flow IndirectDeclaration of unmodified opinion2026-01-012026-03-31AuditedConsolidated3442930000011429000003557220000055495000004983600000-9494000007516000000141750000022308000008030800000287788000006793400000-23160000065618000001928800000-9313000009975000000556430000000029900000559420000028940000058836000005543500000507000002852000004200000412800000113.4413.410013.4413.410.00390.00170.0484Due to limitation of characters in xbrl utility, we are facing constraints to disclose all notes to accounts. Kindly refer PDF version of financials results uploaded on the Stock Exchanges website: www.bseindia.com and www.nseindia.com and also on the Company's website: www.mankindpharma.com.2025-04-012026-03-31AuditedConsolidated1427764000003587900000146364300000228803000001727970000036120000031839000000639280000088618000003424210000012185690000024507400000-1297500000232099000005828900000-188310000039458000000192641000000001169000001938100000057040000019951400000191293000002517000005657000004700000412800000116259060000046.3546.280046.3546.280.00390.00470.0409Other expenses8030800000Other expenses34242100000295956000006547800000500000649263000009168260000047285000000199840000024803000000064480000031251000003247000000351960000020937140000021444800000153731000001729510000039169000009108000004310000024787000004001770000018819000008052500000713969000002700000002807953000004128000001625906000001630034000002607100000165610500000289266000002892660000024865000001839980000002994000005011230000034188800000148690000011926400000134133000007494800000550969000001729100000813740000010910000065072500000115184800000280795300000Other non-current financial assets644800000Other non-current assets3519600000Other current financial assets2478700000Other current assets8052500000Other non-current liabilities299400000Other current financial liabilities7494800000Other current liabilities17291000006392800000-507700000-17204000000-148770000000-125600000021032000000-210300000088618000000243140000005653000000-32010000005805000001824000000000-165430000001393030000037140200000000592730000003121290000000000077500000029900000625960000000011128000000000000003600000000058050000004723900000-196420000000214600000000003978010000062179700000292800000412700000663640000000-29526900000-278200000156300000-12190000040388000003916900000Remeasurement gains/(losses) of the defined benefit plan83300000Share of other comprehensive income/(loss) of associates and joint ventures0Change in the fair value of equity investments at FVTOCI71800000Impairment on investment measured at FVTOCI0155100000Remeasurement gains/(losses) of the defined benefit plan54700000Share of other comprehensive income/(loss) of associates and joint ventures0Change in the fair value of equity investments at FVTOCI326600000Impairment on investment measured at FVTOCI-620000003193000003480000061900000Exchange differences in translating the financial statements of foreign operations169100000169100000Exchange differences in translating the financial statements of foreign operations31300000031300000000289400000570400000AuditedtrueS.R. Batliboi & Co. LLPtrue2027-07-31Bhagi Bhardwaj Gaur & Cotrue2028-05-31